广东药科大学学报2019，Vol.35Issue(1)：102-106,5.DOI:10.16809/j.cnki.2096-3653.2018102402
药品上市许可持有人制度下保险赔偿范围设计研究
Scope of insurance compensation under the institutional arrangement of Marketing Authorization Holder
摘要
Abstract
Objective To analyze the shortcomings and deficiencies of the existing insurance compensation scope, and propose reasonable suggestions for the design of the insurance compensation scope under the Marketing Authorization Holder (MAH) system. Methods Literature research was applied to study the existing national policies about the coverage requirements of drug risk prevention and control, as well as the definition and analysis of related concepts. And the appropriate compensation scope was summarized. Results The coverage of insurance compensation was incomplete and the definition of terms was not clear. Conclusion In the process of designing insurance, "drug defect" should be taken as the insurance coverage of MAH.关键词
药品上市许可持有人制度/保险/赔偿范围Key words
Marketing Authorization Holder/insurance/scope of compensation分类
医药卫生引用本文复制引用
彭楠,柳鹏程,邵蓉..药品上市许可持有人制度下保险赔偿范围设计研究[J].广东药科大学学报,2019,35(1):102-106,5.基金项目
国家社会科学基金重大项目(15ZDB167) （15ZDB167）
